Percutaneous Coronary Intervention Registry FRIBOURG
Cardio-FR
1 other identifier
observational
3,000
1 country
1
Brief Summary
The registry aims to follow clinically all consecutive patients treated by percutaneous coronary interventions at hospital \& university Fribourg.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
November 14, 2019
CompletedFirst Posted
Study publicly available on registry
December 4, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
ExpectedOctober 22, 2021
October 1, 2021
2.3 years
November 14, 2019
October 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Patient-oriented composite endpoints (POCE)
Academic Research Consortium definition
2 years
Major Bleeding
Bleeding Academic Research Consortium definition
2 years
Patient-oriented composite endpoints (POCE)
Academic Research Consortium definition
5 years
Major Bleeding
Bleeding Academic Research Consortium definition
5 years
Patient-oriented composite endpoints (POCE)
Academic Research Consortium definition
10 years
Major Bleeding
Bleeding Academic Research Consortium definition
10 years
Secondary Outcomes (3)
all-cause death
2 years
any revascularization
2 years
any myocardial infarction
2 years
Interventions
Eligibility Criteria
All comers
You may qualify if:
- All consecutive patients treated by percutaneous coronary intervention at our institution
- Able to give informed consent and willing to participate
You may not qualify if:
- Unwillingness to participate
- Enable to provide inform consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiology, university Fribourg Medical Center
Fribourg, 1708, Switzerland
Related Publications (1)
Cook ST, Allemann L, Cook M, Arroyo DA, Pittet T, Meier P, Togni M, Brahim-Mathiron A, Puricel S, Cook S. Sex differences in ST-segment elevation myocardial infarction patients treated by primary percutaneous intervention. Open Heart. 2025 Jan 4;12(1):e002831. doi: 10.1136/openhrt-2024-002831.
PMID: 39756819DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairman, cardiology
Study Record Dates
First Submitted
November 14, 2019
First Posted
December 4, 2019
Study Start
May 1, 2015
Primary Completion
September 1, 2017
Study Completion (Estimated)
September 1, 2027
Last Updated
October 22, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share